2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KCNAB1 mRNA CTD PMID:24680724 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of KCNAB1 mRNA CTD PMID:23537331 3,3',5,5'-tetrabromobisphenol A increases expression ISO KCNAB1 (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of KCNAB1 mRNA CTD PMID:35321852 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of KCNAB1 mRNA CTD PMID:30951980 4-vinylcyclohexene dioxide affects expression EXP 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of KCNAB1 mRNA CTD PMID:20829426 6-propyl-2-thiouracil decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of KCNAB1 mRNA CTD PMID:24780913 and PMID:30047161 acetamide decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 acetamide results in decreased expression of KCNAB1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of KCNAB1 mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO KCNAB1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of KCNAB1 5' UTR more ... CTD PMID:27153756 and PMID:30157460 Aflatoxin B2 alpha increases methylation ISO KCNAB1 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of KCNAB1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO KCNAB1 (Homo sapiens) 6480464 Tretinoin results in increased expression of KCNAB1 mRNA CTD PMID:21934132 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of KCNAB1 mRNA CTD PMID:15520326 amitrole decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of KCNAB1 mRNA CTD PMID:30047161 ammonium chloride affects expression ISO Kcnab1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of KCNAB1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO KCNAB1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of KCNAB1 mRNA CTD PMID:33212167 atrazine affects methylation ISO Kcnab1 (Rattus norvegicus) 6480464 Atrazine affects the methylation of KCNAB1 gene CTD PMID:35440735 benzo[a]pyrene increases mutagenesis ISO KCNAB1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased mutagenesis of KCNAB1 gene CTD PMID:25435355 benzo[a]pyrene increases methylation ISO KCNAB1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of KCNAB1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO KCNAB1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of KCNAB1 exon and Benzo(a)pyrene affects the methylation of KCNAB1 intron CTD PMID:27901495 and PMID:30157460 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of KCNAB1 intron CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of KCNAB1 mRNA CTD PMID:22228805 benzo[a]pyrene affects expression ISO KCNAB1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of KCNAB1 mRNA CTD PMID:22316170 benzo[e]pyrene affects methylation ISO KCNAB1 (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of KCNAB1 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of KCNAB1 mRNA CTD PMID:15674843 bisphenol A affects expression ISO Kcnab1 (Rattus norvegicus) 6480464 bisphenol A affects the expression of KCNAB1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KCNAB1 mRNA CTD PMID:32156529 bisphenol A affects methylation ISO KCNAB1 (Homo sapiens) 6480464 bisphenol A affects the methylation of KCNAB1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of KCNAB1 gene CTD PMID:31601247 bisphenol A increases expression ISO Kcnab1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of KCNAB1 mRNA CTD PMID:33296240 bisphenol A decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of KCNAB1 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of KCNAB1 mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KCNAB1 mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KCNAB1 mRNA CTD PMID:24982889 cadmium dichloride multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KCNAB1 mRNA CTD PMID:35301059 CGP 52608 multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to KCNAB1 gene] CTD PMID:28238834 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNAB1 mRNA CTD PMID:20938992 cisplatin decreases expression ISO KCNAB1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of KCNAB1 mRNA CTD PMID:27392435 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of KCNAB1 mRNA CTD PMID:21139344 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of KCNAB1 mRNA CTD PMID:18000554 cocaine affects expression ISO Kcnab1 (Rattus norvegicus) 6480464 Cocaine affects the expression of KCNAB1 mRNA CTD PMID:20187946 Cuprizon decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of KCNAB1 mRNA CTD PMID:26577399 decabromodiphenyl ether decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of KCNAB1 mRNA CTD PMID:23640034 dexamethasone decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of KCNAB1 mRNA CTD PMID:20032058 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of KCNAB1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO Kcnab1 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KCNAB1 mRNA] CTD PMID:20032058 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNAB1 mRNA CTD PMID:29950665 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of KCNAB1 mRNA CTD PMID:25447406 dioxygen decreases expression ISO KCNAB1 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of KCNAB1 mRNA CTD PMID:26516004 disodium selenite decreases expression ISO KCNAB1 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of KCNAB1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNAB1 mRNA CTD PMID:27188386 entinostat multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNAB1 mRNA CTD PMID:27188386 entinostat decreases expression ISO KCNAB1 (Homo sapiens) 6480464 entinostat results in decreased expression of KCNAB1 mRNA CTD PMID:26272509 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of KCNAB1 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of KCNAB1 mRNA CTD PMID:30319688 fenvalerate increases expression ISO Kcnab1 (Rattus norvegicus) 6480464 fenvalerate results in increased expression of KCNAB1 mRNA CTD PMID:30307764 flutamide increases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Flutamide results in increased expression of KCNAB1 mRNA CTD PMID:24793618 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNAB1 mRNA CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of KCNAB1 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of KCNAB1 gene CTD PMID:31601247 genistein increases expression EXP 6480464 Genistein results in increased expression of KCNAB1 mRNA CTD PMID:16169203 gentamycin decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of KCNAB1 mRNA CTD PMID:22061828 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of KCNAB1 mRNA CTD PMID:18797397 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KCNAB1 mRNA CTD PMID:20938992 lead diacetate multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCNAB1 mRNA CTD PMID:22839698 lipopolysaccharide multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCNAB1 mRNA CTD PMID:35811015 mercury dichloride decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Mercuric Chloride results in decreased expression of KCNAB1 mRNA CTD PMID:16507785 methapyrilene affects methylation ISO KCNAB1 (Homo sapiens) 6480464 Methapyrilene affects the methylation of KCNAB1 intron CTD PMID:30157460 methimazole decreases expression ISO Kcnab1 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of KCNAB1 mRNA CTD PMID:30047161 methoxychlor affects expression EXP 6480464 Methoxychlor affects the expression of KCNAB1 mRNA CTD PMID:20829426 methylseleninic acid increases expression ISO KCNAB1 (Homo sapiens) 6480464 methylselenic acid results in increased expression of KCNAB1 mRNA CTD PMID:18548127 N-nitrosodiethylamine multiple interactions EXP 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of KCNAB1 mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of KCNAB1 mRNA CTD PMID:17942915 nickel atom decreases expression ISO KCNAB1 (Homo sapiens) 6480464 Nickel results in decreased expression of KCNAB1 mRNA CTD PMID:24768652 and PMID:25583101 olanzapine decreases expression EXP 6480464 olanzapine results in decreased expression of KCNAB1 mRNA CTD PMID:18797397 oxaliplatin multiple interactions ISO Kcnab1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KCNAB1 mRNA CTD PMID:25729387 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCNAB1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCNAB1 mRNA CTD PMID:27188386 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of KCNAB1 mRNA CTD PMID:37682722 testosterone multiple interactions ISO Kcnab1 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KCNAB1 mRNA] CTD PMID:20032058 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNAB1 mRNA CTD PMID:29950665 topotecan multiple interactions ISO Kcnab1 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of KCNAB1 mRNA CTD PMID:25729387 valproic acid increases expression ISO KCNAB1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of KCNAB1 mRNA CTD PMID:24383497 and PMID:28001369 vinclozolin decreases methylation ISO Kcnab1 (Rattus norvegicus) 6480464 vinclozolin results in decreased methylation of KCNAB1 gene CTD PMID:31682807 zinc protoporphyrin multiple interactions ISO KCNAB1 (Homo sapiens) 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCNAB1 mRNA CTD PMID:22839698